4.3 Article

Reducing Uncertainty in Value-Based Pricing Using Evidence Development Agreements The Case of Continuous Intraduodenal Infusion of Levodopa/Carbidopa (Duodopa®) in Sweden

Related references

Note: Only part of the references are listed.